Browsing: Health

The European Medicines Agency (EMA) has issued a positive recommendation for the authorization of lenacapavir, a twice-yearly injectable medication for HIV prevention. Marketed in Europe under the name Yeytuo by Gilead Sciences, the drug is now positioned for formal approval by the European Commission, which would allow its use across all 27 European Union member states, along with Iceland, Norway and Liechtenstein. Lenacapavir is a pre-exposure prophylaxis (PrEP) medication that has demonstrated near-total effectiveness in preventing HIV transmission. In two large Phase 3 clinical trials, PURPOSE 1 and PURPOSE 2, the drug was found to be 100 percent effective among women in sub-Saharan Africa and 99.9 percent…

Read More

A newly published study led by researchers at Mount Sinai has identified a significant association between exposure to per- and polyfluoroalkyl substances (PFAS) and an increased risk of developing type 2 diabetes. The findings, released in the peer-reviewed journal eBioMedicine, contribute to growing scientific concern over the long-term health impacts of these persistent environmental chemicals. PFAS, often referred to as “forever chemicals,” are synthetic compounds widely used in the production of nonstick cookware, waterproof clothing, stain-resistant textiles, and various industrial applications. PFAS chemicals are commonly found in household items like cookware and textiles Known for their resistance to degradation, PFAS…

Read More

Health authorities in Western Australia are responding to a suspected measles outbreak linked to a remote mining site and a member of Qantas Airways flight staff. The outbreak is believed to have originated in the town of Newman, a remote mining community in the Pilbara region, where BHP operates a significant mining operation. According to reports, the initial case was identified in a miner who had been working at the BHP Newman site in early July. Following this case, BHP confirmed it is monitoring a second employee who has tested positive for measles, with several other workers placed in isolation as a precaution…

Read More

Australian regulators are reviewing a proposal to approve the cultivation and sale of a genetically modified purple tomato, potentially expanding the nation’s limited list of approved genetically modified (GM) crops. If successful, the tomato could be commercially available by next year, with initial production planned in greenhouses in south-east Queensland. Developed by UK-based scientists and commercialized by U.S. firm Norfolk Healthy Produce, the purple tomato has been engineered to contain genes from the snapdragon flower. These genes enable the tomato to produce anthocyanins, naturally occurring antioxidants also found in blueberries, blackberries, and eggplant skins. The resulting pigmentation gives the tomato its distinct purple hue.…

Read More